This RFP aims to harness bioengineering technology to solve the problems posed by the HIV viral reservoir through collaborations between HIV cure scientists and bioengineers. Recent advances in nanomachines, synthetic biomarkers, in vivo sensors, multi-omic single cell platforms and other technologies have yet to be evaluated for their usefulness in curing HIV. Investment Grants provide a funding mechanism through which potentially groundbreaking, early stage approaches are encouraged, regardless of risk or scalability.
Click here to view the full RFP
Maximum Funding: $1.5 million including indirect costs
Performance Period: February 1, 2017 – January 31, 2021
Deadline to request log-in credentials for submission: 3:00 PM, Friday, September 23, 2016.
Deadline to submit Letter of Intent: 3:00 PM, Tuesday, September 27, 2016
Click here to submit a request for log-in credentials for this RFP
Eligibility
The Principal Investigator must hold a doctoral degree and be an HIV cure scientist affiliated with a nonprofit research institution. Please refer to the RFP for full eligibility requirements.
